It is with great sadness that EMAS has learnt of the death of Fernand Labrie at the age of 81. A pioneering Canadian endocrinologist, his interests encompassed both women’s and men’s health. He was an international expert whose most recent innovation was developing and obtaining regulatory approval for vaginal dehydroepiandrosterone for menopause.
He will be greatly missed worldwide.
EMAS Executive Director